My heart goes out to you and your family.

I'm sure you're aware of the new biosimilar out there called Erelzi. It won't be out until late 2018-2019 due to legal battles with the patent holder of Enbrel.

Here's what makes me furious. There are legal loopholes that pharmaceutical companies have been taking advantage of for decades now. Called "Pay to Delay," these companies are using legal tactics to delay other companies from bringing cheaper generics/biologics to market just so they can profit a few more years off their original patent. This happens for EVERY drug. How many patients & families have faced the financial struggles because of greed? This is why I'm taking a stand and doing something about it.

Here's reference to the loophole I mentioned: http://californiahealthline.org/morning-breakout/drug-companies-use-loopholes-in-hatchwaxman-act-to-delay-generic-competition-ftc-report-says/

As for HIPAA & security, well, that is one of the strongest benefits of blockchain technology. I'll get into detail with this when I release the technical whitepaper. I've also been dealing with HIPAA for the past few years with my previous company. Those outdated laws are seriously hampering innovation.